Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide
Abdulla A.‐B. Badawy
Bioscience Reports (2020) Vol. 40, Iss. 10
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Tryptophan metabolism and disposition in cancer biology and immunotherapy
Abdulla A.‐B. Badawy
Bioscience Reports (2022) Vol. 42, Iss. 11
Open Access | Times Cited: 42
CD38 in the age of COVID-19: a medical perspective
Alberto L. Horenstein, Angelo Corso Faini, Fabio Malavasi
Physiological Reviews (2021) Vol. 101, Iss. 4, pp. 1457-1486
Open Access | Times Cited: 47
The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy
Abdulla A.‐B. Badawy
Bioscience Reports (2023) Vol. 43, Iss. 8
Open Access | Times Cited: 19
The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects
Luana de Fátima Alves, J. Bernadette Moore, Douglas B. Kell
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9082-9082
Open Access | Times Cited: 6
ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions
Daniel J. Rawle, Thuy T. Le, Troy Dumenil, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 7, pp. e1009723-e1009723
Open Access | Times Cited: 40
SARS-CoV-2 infection dysregulates NAD metabolism
Amin Izadpanah, Joseph C. Mudd, Joe G. N. Garcia, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Molecular Insights into the Interaction of Tryptophan Metabolites with the Human Aryl Hydrocarbon Receptor in Silico: Tryptophan as Antagonist and no Direct Involvement of Kynurenine
Abdulla A.‐B. Badawy, Shazia Dawood
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 9
Open Access | Times Cited: 5
The PARP Way to Epigenetic Changes
Simone Ummarino, Clinton Hausman, Annalisa Di Ruscio
Genes (2021) Vol. 12, Iss. 3, pp. 446-446
Open Access | Times Cited: 25
A glimpse into viral warfare: decoding the intriguing role of highly pathogenic coronavirus proteins in apoptosis regulation
Leyi Cheng, Yajuan Rui, Yanpu Wang, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 3
NAD+ Metabolism, Metabolic Stress, and Infection
Benjamin Groth, Padmaja Venkatakrishnan, Su-Ju Lin
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 22
Species Differences in Tryptophan Metabolism and Disposition
Abdulla A.‐B. Badawy, Gilles J. Guillemin
International Journal of Tryptophan Research (2022) Vol. 15
Open Access | Times Cited: 16
NAD+ metabolism and therapeutic strategies in cardiovascular diseases
Chongxu Shi, Zhao-Zhi Wen, Yihang Yang, et al.
Atherosclerosis Plus (2024) Vol. 57, pp. 1-12
Open Access | Times Cited: 3
Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases
Noemí Rotllán, Mercedes Camacho, Mireia Tondo, et al.
Antioxidants (2021) Vol. 10, Iss. 12, pp. 1939-1939
Open Access | Times Cited: 19
Potential Efficacy of Nutrient Supplements for Treatment or Prevention of COVID-19
Katrina Bogan-Brown, Yasmeen Nkrumah‐Elie, Yusrah Ishtiaq, et al.
Journal of Dietary Supplements (2021) Vol. 19, Iss. 3, pp. 336-365
Open Access | Times Cited: 16
Therapeutic Significance of microRNA-Mediated Regulation of PARP-1 in SARS-CoV-2 Infection
Sabyasachi Dash, Chandravanu Dash, Jui Pandhare
Non-Coding RNA (2021) Vol. 7, Iss. 4, pp. 60-60
Open Access | Times Cited: 16
Nicotinamide pathways as the root cause of sepsis – an evolutionary perspective on macrophage energetic shifts
Melinda Suchard, Dana Savulescu
FEBS Journal (2021) Vol. 289, Iss. 4, pp. 955-964
Open Access | Times Cited: 15
Tryptophan Metabolism ‘Hub’ Gene Expression Associates with Increased Inflammation and Severe Disease Outcomes in COVID-19 Infection and Inflammatory Bowel Disease
Sonia Bustamante, Yunki Yau, Victoria Boys, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14776-14776
Open Access | Times Cited: 11
The use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma
Samuel Goulart Nacácio e Silva, Marcelo Luís Occhiutto, Vital Paulino Costa
European Journal of Ophthalmology (2023) Vol. 33, Iss. 5, pp. 1801-1815
Closed Access | Times Cited: 6
Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors
Shailima Rampogu, Tae Sung Jung, Min Woo Ha, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
The result of prospective randomized study CITADEL — the efficacy and safety of drug cytoflavin in postcovid rehabilitation
M. V. Putilina, Natalia V. Teplova, K I Bairova, et al.
S S Korsakov Journal of Neurology and Psychiatry (2021) Vol. 121, Iss. 10, pp. 45-45
Closed Access | Times Cited: 14
Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy
I. Yu. Torshin, О. А. Громова, А. Г. Чучалин, et al.
FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology (2021) Vol. 14, Iss. 2, pp. 191-211
Open Access | Times Cited: 13
Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibility
Amin Daei Sorkhabi, Aila Sarkesh, Alireza Daei Sorkhabi, et al.
Journal of Basic and Clinical Physiology and Pharmacology (2021) Vol. 33, Iss. 1, pp. 55-77
Open Access | Times Cited: 13
Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus–Host Interactome
Jiansong Fang, Qihui Wu, Fei Ye, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 11
Pathogenetic and pharmacodynamic features of succinic acid derivative application for various diseases of the cardiovascular and nervous systems
А. Е. Ким, Е. Б. Шустов, Vyacheslav P. Ganapolsky
Psychopharmacology & biological narcology (2024) Vol. 15, Iss. 1, pp. 7-22
Open Access | Times Cited: 1
Potential association between COVID-19 and neurological disorders: analysis of common genes and therapeutics
Wenzhi Chen, Shishi Jiang, Li Cheng, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top